(See Non-Arteritic Anterior Ischemic Optic Neuropathy and GLP-1 Agonists, below.) With the recent popularity of this second-line treatment for type 2 diabetes and obesity and the latest research, we can play a crucial role in identifying progressive disease
Qsymia is a once-daily oral combination of phentermine (an appetite suppressant) and topiramate (originally developed for seizures and migraines), and the two together produce stronger and more durable results than phentermine alone
* We offer Care Credit financing * We offer Care Credit 6 months 0% financing, (6 month 0% financing for charges over $1,000, or 24 & 36 months with interest.) Have busy schedule
The clinical manifestations of ALS usually appear between 5060 years of age, suggesting that neurons die through cumulative damage to normal cellular processes
Six (60%) men and four (40%) women comprised the CAD group assigned as Group 1, while 6 (60%) men and 4 (40%) women with normal coronary arteries on angiograms as Group 2
Modulation of glutamatergic transmission by sulfated steroids: role in fetal alcohol spectrum disorder